Bioactive Compounds
-
B1305 SKLB1002Summary: VEGFR2 inhibitor,potent and ATP-competitve -
B1149 GSK962040Summary: Motilin receptor agonist -
B5421 (Z)-4-Hydroxytamoxifen2 CitationTarget: Estrogen and Related ReceptorsSummary: ER modulator, potent and selective -
B5639 A 412997 dihydrochlorideSummary: Selective D4 agonist -
A8881 WZ3146Summary: Mutant EGFR inhibitor, potent and irreversible -
B6014 BI-847325Summary: dual inhibitor of MEK and Aurora kinases -
A8736 THZ531Target: Cyclin-Dependent KinasesSummary: CDK12 and CDK13 covalent inhibitor -
A1026 β-Interleukin I (163-171), humanSummary: T cell activator -
C6678 4-Amino-L-phenylalanine -
B6168 OICR-94293 CitationSummary: Wdr5-MLL interaction antagonist

